3-ethyl-1-(trimethylsilylethynyl)benzene | 1065169-08-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-ethyl-1-(trimethylsilylethynyl)benzene
• 英文别名: ((3-ethylphenyl)ethynyl)trimethylsilane；2-(3-ethylphenyl)ethynyl-trimethylsilane
• CAS: 1065169-08-5
• 化学式: C₁₃H₁₈Si
• 分子量: 202.371
• InChiKey: FHFKOIGIYGFZNC-UHFFFAOYSA-N

物化性质

• 沸点：
  248.8±23.0 °C(Predicted)
• 密度：
  0.90±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.48
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  3-ethyl-1-(trimethylsilylethynyl)benzene 在 potassium fluoride 、 copper(l) iodide 、 叠氮基三甲基硅烷 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 4-(3-ethylphenyl)-1H-1,2,3-triazole
  参考文献：
  名称：

  Rational Design of 4-Aryl-1,2,3-Triazoles for Indoleamine 2,3-Dioxygenase 1 Inhibition

  摘要：

  Indoleamine 2,3-dioxygenase 1 (IDO1) is an important therapeutic target treatment of diseases such as cancer that involve pathological immune escape. Starting from the scaffold of our previously discovered IDO1 inhibitor 4-phenyl-1,2,3-triazole, we used computational structure-based methods to design more potent ligands. This approach yielded highly efficient low molecular weight inhibitors, the most active being of nanomolar potency both in an enzymatic and in a cellular assay, while showing no cellular toxicity and a high selectivity for IDO1 over tryptophan 2,3-dioxygenase (TDO). A quantitative structure-activity relationship based on the electrostatic ligand-protein interactions in the docked binding modes and on the quantum chemically derived charges of the triazole ring demonstrated a good explanatory power for the observed activities.

  DOI：

  10.1021/jm300260v
• 作为产物：
  描述：

  1-乙基-3-碘苯 、 三甲基乙炔基硅 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodide 、 三乙胺 作用下， 以 1,4-二氧六环 为溶剂， 反应 5.0h， 生成 3-ethyl-1-(trimethylsilylethynyl)benzene
  参考文献：
  名称：

  Rational Design of 4-Aryl-1,2,3-Triazoles for Indoleamine 2,3-Dioxygenase 1 Inhibition

  摘要：

  Indoleamine 2,3-dioxygenase 1 (IDO1) is an important therapeutic target treatment of diseases such as cancer that involve pathological immune escape. Starting from the scaffold of our previously discovered IDO1 inhibitor 4-phenyl-1,2,3-triazole, we used computational structure-based methods to design more potent ligands. This approach yielded highly efficient low molecular weight inhibitors, the most active being of nanomolar potency both in an enzymatic and in a cellular assay, while showing no cellular toxicity and a high selectivity for IDO1 over tryptophan 2,3-dioxygenase (TDO). A quantitative structure-activity relationship based on the electrostatic ligand-protein interactions in the docked binding modes and on the quantum chemically derived charges of the triazole ring demonstrated a good explanatory power for the observed activities.

  DOI：

  10.1021/jm300260v

文献信息

• AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF BETA-SECRETASE
  申请人：Malamas Michael Sotirios

  公开号：US20090048320A1

  公开（公告）日：2009-02-19

  The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.

  本发明提供了化合物和方法，用于抑制β-分泌酶（BACE）并治疗β-淀粉样沉积物和神经原纤维缠结。
• Tandem Catalytic C(sp³)H Amination/Sila-Sonogashira-Hagihara Coupling Reactions with Iodine Reagents
  作者：Julien Buendia、Benjamin Darses、Philippe Dauban

  DOI：10.1002/anie.201412364

  日期：2015.5.4

  A new tandem CN and CC bond‐forming reaction has been achieved through RhII/Pd0 catalysis. The sequence first involves an iodine(III) oxidant, then the in situ generated iodine(I) by‐product is used as a coupling partner. The overall process demonstrates the synthetic value of iodoarenes produced in trivalent iodine reagent mediated oxidations.

  通过Rh II / Pd 0催化实现了一个新的串联CN和CC键形成反应。该序列首先涉及碘（III）氧化剂，然后将原位生成的碘（I）副产物用作偶联伴侣。整个过程证明了在三价碘试剂介导的氧化反应中产生的碘代芳烃的合成价值。
• Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase
  申请人：Malamas Michael Sotirios

  公开号：US20100168194A1

  公开（公告）日：2010-07-01

  The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.

  本发明提供了化合物和方法，用于抑制β-分泌酶（BACE）并治疗β淀粉样沉积和神经纤维缠结。
• Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase
  申请人：Wyeth LLC

  公开号：US07723368B2

  公开（公告）日：2010-05-25

  The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.

  本发明提供了化合物和使用方法，用于抑制β-分泌酶（BACE）并治疗β-淀粉样沉积物和神经纤维缠结。